Robotic-Assisted Surgery in Cancers: New Technologies and New Strategies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 1169
Special Issue Editor
Interests: indocyanine green fluorescence; anastomotic leak; robotic surgery; colorectal surgery
Special Issue Information
Dear Colleagues,
Colorectal cancer (CRC) is the third most common tumor in men and the second most common in women. Actually, it is the fourth most common cancer-related cause of death globally. To obtain the state of the art, CRC treatment must be multidisciplinary in order to ensure personalized therapies according to the disease’s evolution. Nevertheless, colorectal surgery represents the cornerstone in CRC treatment. It alone has proved to be sufficient in terms of OS and DFS in the lower stages, while in the advanced stages, it retains its role in combination with chemotherapy, radiotherapy, and, in limited cases, with metastasis surgery. Colorectal surgery can be followed by complications such as bleeding, infections, and stenosis, but anastomotic leak (AL) remains the most feared by surgeons.
Anastomotic leak is one of the most severe complications in colorectal surgery, with it having correlations to a higher mortality rate. It has several risk factors, but the vascularization of the colic stumps plays a central role in the onset process. With the development of minimally invasive surgery, many studies have noted the benefits of indocyanine green fluorescence and demonstrated its efficacy and safety in the evaluation of visceral ischemia. The limits of this method are linked to operator dependence in the evaluation of arterial perfusion and venous outflow, but the arrival of robotic surgery and new generation systems represent a hope of overcoming them.
Dr. Marcello Gasparrini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- indocyanine green fluorescence
- anastomotic leak
- robotic surgery
- colorectal surgery
